M&G »

Alnylam Pharmaceuticals shares owned by M&G

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by M&G from 13F filings

Historical chart of M&G investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by M&G consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by M&G

Quarter filed Position value Share count Share price at filing
2026-03-31 $13M 38k 331.00

More positions owned by M&G

Microsoft Corporation (MSFT)
Amcor Com New (AMCR)
Astrazeneca Ord (AZN)
Methanex Corp (MEOH)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
V.F. Corporation (VFC)
Nextera Energy (NEE)
Broadcom (AVGO)
Bristol Myers Squibb (BMY)
Wells Fargo & Company (WFC)
Medtronic SHS (MDT)
Totalenergies Se Act (TTE)
Apple (AAPL)
Equinix (EQIX)

View all positions for M&G

Top funds holding Alnylam Pharmaceuticals

FMR
Vanguard Group
Capital World Investors
BlackRock
Capital Research Global Investors
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
Geode Capital Management
Baillie Gifford & Co
Two Sigma Investments
Dodge & Cox
T. Rowe Price Investment Management
Wellington Management Company
American Century Companies

View all funds holding Alnylam Pharmaceuticals